Nicox

en fr

About Us
Pipeline, Markets and Science
Investors
News and Events
Contact Us

Nicox, Bausch + Lomb Glaucoma Candidate BOL-303259-X Meets Primary Endpoint in Phase 2b Study; Bausch + Lomb to Pursue Global Phase 3 Development Program

March 12, 2012

← Back to blog page

Nicox

Contact Us
Subscribe to news
Legal Notice

Search

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.